Document is current
Any future updates will be listed below
-
Authors
Luecken, Malte D. https://orcid.org/0000-0001-7464-7921
Gigante, Scott https://orcid.org/0000-0002-4544-2764
Burkhardt, Daniel B.
Cannoodt, Robrecht https://orcid.org/0000-0003-3641-729X
Strobl, Daniel C.
Markov, Nikolay S.
Zappia, Luke https://orcid.org/0000-0001-7744-8565
Palla, Giovanni https://orcid.org/0000-0002-8004-4462
Lewis, Wesley
Dimitrov, Daniel
Vinyard, Michael E.
Magruder, D. S.
Mueller, Michaela F.
Andersson, Alma https://orcid.org/0000-0002-4773-9975
Dann, Emma https://orcid.org/0000-0002-7400-7438
Qin, Qian https://orcid.org/0000-0002-2119-6263
Otto, Dominik J. https://orcid.org/0000-0002-6116-053X
Klein, Michal
Botvinnik, Olga Borisovna
Deconinck, Louise https://orcid.org/0000-0001-8100-6823
Waldrant, Kai https://orcid.org/0009-0003-8555-1361
Yasa, Sai Nirmayi
Szałata, Artur https://orcid.org/0000-0001-8413-234X
Benz, Andrew
Li, Zhijian https://orcid.org/0000-0002-1523-1333
,
Rieck, Bastian
Ahlmann-Eltze, Constantin
da Veiga Beltrame, Eduardo
Bravo González-Blas, Carmen
Chen, Ann T.
DeMeo, Benjamin
Ergen, Can
Floc’hlay, Swann
Gayoso, Adam https://orcid.org/0000-0001-9537-0845
Hicks, Stephanie https://orcid.org/0000-0002-7858-0231
Ji, Yuge
Kleshchevnikov, Vitalii
La Manno, Gioele https://orcid.org/0000-0003-1428-8757
Lombardo, Maximilian G.
Lopez, Romain https://orcid.org/0000-0003-0495-738X
Righelli, Dario https://orcid.org/0000-0003-1504-3583
Sarkar, Hirak
Svensson, Valentine https://orcid.org/0000-0002-9217-2330
Tong, Alexander
Xing, Galen
Xu, Chenling
Bloom, Jonathan M.
Pisco, Angela Oliveira
Saez-Rodriguez, Julio
Wulsin, Drausin
Pinello, Luca https://orcid.org/0000-0003-1109-3823
Saeys, Yvan https://orcid.org/0000-0002-0415-1506
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
Krishnaswamy, Smita https://orcid.org/0000-0001-5823-1985
- License Information
-
More Information
Article History
First Online: 1 July 2025
Competing interests
: M.D.L. consults for CatalYm GmbH, contracted for the Chan Zuckerberg Initiative and received speaker fees from Pfizer and Janssen Pharmaceuticals. S.G. has equity interest in Immunai Inc. D.B.B. is a paid employee of and has equity interest in NVIDIA. R.C. has equity interest in Data Intuitive BV. L.Z. has consulted for Lamin Labs GmbH. W.L. contracted for Protein Evolution Incorporated. From 2019 to 2022, A.A. was a consultant for 10x Genomics. From October 2023, E.D. has been a consultant for EnsoCell Therapeutics. O.B.B is currently an employee of Bridge Bio Pharma. A.S. consults for Cellarity Inc. and Exvivo Labs Inc. A.B. is a paid employee of and has equity interest in Cellarity, Inc. J.B. has equity interest in Cellarity, Inc. J.S.-R. reports funding from GSK, Pfizer and Sanofi and fees or honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer and Grunenthal. D.W. has equity interest in Immunai Inc. F.J.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd and Cellarity, and has ownership interest in Dermagnostix GmbH and Cellarity. S.K. is a visiting professor at Meta and scientific advisor at Ascent Bio, Inc. E.d.V.B has ownership interest in Retro Biosciences and ImYoo Inc and is employed by ImYoo Inc. A.T.C. is an employee of Orion Medicines. B.D. is a paid employee of and has equity interest in Cellarity Inc. A.G. is currently an employee of Google DeepMind. Google DeepMind has not directed any aspect of this study nor exerts any commercial rights over the results. R.L. is an employee of Genentech. V.S. has ownership interest in Altos Labs and Vesalius Therapeutics. A.T. has an ownership interest in Dreamfold.
